Featured

  • cGMP Manufacture | Industry News
    NJ Innovation Institute, Rutgers form Continuous Mfg. Institute

    NJ Innovation Institute, Rutgers form Continuous Mfg. Institute

    Will serve as a center of excellence to advance new pharmaceutical manufacturing technologies
    10.17.17
  • Industry News
    CPhI Report Highlights Anticipated CDMO Market Trends

    CPhI Report Highlights Anticipated CDMO Market Trends

    Niche services and technologies to dominate future acquisitions, increase in flow chemistry, fermentation anticipated
    10.17.17
  • Bio News | Breaking News | Facilities | Industry News | Validation
    FDA Approves Samsung Biologics’ Second Plant

    FDA Approves Samsung Biologics’ Second Plant

    Contract manufacturer gets the ‘green light’ for commercial production at 152,000-liter plant
    10.16.17
  • cGMP Manufacture | Industry News | Solid Dosage/ Creams/ Ointments
    Tulex Completes NJ Development and Manufacturing Facility

    Tulex Completes NJ Development and Manufacturing Facility

    cGMP facility capable of handling solvent processing and Wurster coating for commercial scale oral solid and liquid dose
    10.13.17
  • cGMP Manufacture | Industry News
    Sanofi Invests €170M in New Vaccine Facility in France

    Sanofi Invests €170M in New Vaccine Facility in France

    Will allow Sanofi Pasteur to expand the global supply of its new quadrivalent influenza vaccine VaxigripTetra
    10.13.17
  • Breaking News | Industry News | Regulatory Affairs
    PBOA Hosts First Members Meeting & Conference

    PBOA Hosts First Members Meeting & Conference

    Inaugural event drew high-level FDA speakers and 20 member companies
    10.12.17
  • Regulatory Affairs
    ANDA Refuse-to-Receive Pitfalls and How to Avoid Them

    ANDA Refuse-to-Receive Pitfalls and How to Avoid Them

    A review of FDA expectations
    Jean Poulos, Lachman Consultants 10.11.17
  • CMOs/CDMOs: Challenges and Opportunities

    CMOs/CDMOs: Challenges and Opportunities

    Protectionism, consolidation, immigration, drug pricing and regulatory issues
    Gil Roth, PBOA 10.11.17
  • Maximizing Strategic External Service Provider Relationships In-House

    Maximizing Strategic External Service Provider Relationships In-House

    Insourcing means exclusively managed external services offered by the laboratory service provider in client environments tha
    Beth DiPaolo, Eurofins Lancaster Laboratories PSS Insourcing Solutions 10.11.17
  • The Future of Inhaled Medications and Inhalation Technology

    The Future of Inhaled Medications and Inhalation Technology

    Formulations, devices and strategy through non-clinical development
    Simon Moore, Envigo 10.11.17
  • CEO Spotlight: Samsung Biologics

    CEO Spotlight: Samsung Biologics

    A conversation with Samung Biologics CEO, Dr. TH Kim
    Tim Wright, Contract Pharma 10.11.17
  • CEO Spotlight: Catalent

    CEO Spotlight: Catalent

    A conversation with John Chiminski, CEO of Catalent Pharma Solutions
    Tim Wright, Contract Pharma 10.11.17
  • The Challenges of Drug Development

    The Challenges of Drug Development

    As recorded in two new worthwhile books
    Michael A. Martorelli, Fairmount Partners 10.11.17
  • Digital Drug Delivery: A Snapshot in Time

    Digital Drug Delivery: A Snapshot in Time

    Technology is transforming the future of drug delivery
    Sam Van Alstyne, 3M Drug Delivery Systems 10.11.17
  • Aseptic Processing | Injectables
    Sterile Manufacturing Future Trends and Challenges

    Sterile Manufacturing Future Trends and Challenges

    By the middle of this century, biopharmaceuticals are set to overtake all other pharma sales
    Igor Gorsky, Concordia Valsource 10.11.17